Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-12-03

FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA granted a supplemental approval for Desmopressin Acetate from Apotex Corp. under an ANDA, authorizing its generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desmopressin Acetate (generic) (Desmopressin Acetate)

Snippet

SUPPL AP for DESMOPRESSIN ACETATE (DESMOPRESSIN ACETATE)